BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 27138103)

  • 41. Secretome of tumor-associated leukocytes augment epithelial-mesenchymal transition in positive lymph node breast cancer patients via activation of EGFR/Tyr845 and NF-κB/p65 signaling pathway.
    Elghonaimy EA; Ibrahim SA; Youns A; Hussein Z; Nouh MA; El-Mamlouk T; El-Shinawi M; Mostafa Mohamed M
    Tumour Biol; 2016 Sep; 37(9):12441-12453. PubMed ID: 27329104
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Curcumol Suppresses Breast Cancer Cell Metastasis by Inhibiting MMP-9 Via JNK1/2 and Akt-Dependent NF-κB Signaling Pathways.
    Ning L; Ma H; Jiang Z; Chen L; Li L; Chen Q; Qi H
    Integr Cancer Ther; 2016 Jun; 15(2):216-25. PubMed ID: 27125675
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Iron stimulates urokinase plasminogen activator expression and activates NF-kappa B in human prostate cancer cells.
    Ornstein DL; Zacharski LR
    Nutr Cancer; 2007; 58(1):115-26. PubMed ID: 17571974
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Transcriptional and post-translational regulation of Bim is essential for TGF-β and TNF-α-induced apoptosis of gastric cancer cell.
    Ha Thi HT; Lim HS; Kim J; Kim YM; Kim HY; Hong S
    Biochim Biophys Acta; 2013 Jun; 1830(6):3584-92. PubMed ID: 23500081
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Gambogic acid suppresses cancer invasion and migration by inhibiting TGFβ1-induced epithelial-to-mesenchymal transition.
    Zhao K; Zhang S; Song X; Yao Y; Zhou Y; You Q; Guo Q; Lu N
    Oncotarget; 2017 Apr; 8(16):27120-27136. PubMed ID: 28404892
    [TBL] [Abstract][Full Text] [Related]  

  • 46. PMLIV overexpression promotes TGF-β-associated epithelial-mesenchymal transition and migration in MCF-7 cancer cells.
    Liu Y; Wang JX; Huang D; Wang B; Li LL; Li XX; Ni P; Dong XL; Xia W; Yu CX; Xu WL; Chu WF; Zhao D
    J Cell Physiol; 2018 Dec; 233(12):9575-9583. PubMed ID: 29943817
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Targeted Co-delivery of the Iron Chelator Deferoxamine and a HIF1α Inhibitor Impairs Pancreatic Tumor Growth.
    Lang J; Zhao X; Wang X; Zhao Y; Li Y; Zhao R; Cheng K; Li Y; Han X; Zheng X; Qin H; Geranpayehvaghei M; Shi J; Anderson GJ; Hao J; Ren H; Nie G
    ACS Nano; 2019 Feb; 13(2):2176-2189. PubMed ID: 30676731
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Iron Enhances Hepatic Fibrogenesis and Activates Transforming Growth Factor-β Signaling in Murine Hepatic Stellate Cells.
    Mehta KJ; Coombes JD; Briones-Orta M; Manka PP; Williams R; Patel VB; Syn WK
    Am J Med Sci; 2018 Feb; 355(2):183-190. PubMed ID: 29406047
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Ferroptosis is induced following siramesine and lapatinib treatment of breast cancer cells.
    Ma S; Henson ES; Chen Y; Gibson SB
    Cell Death Dis; 2016 Jul; 7(7):e2307. PubMed ID: 27441659
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Deferoxamine-induced high expression of TfR1 and DMT1 enhanced iron uptake in triple-negative breast cancer cells by activating IL-6/PI3K/AKT pathway.
    Chen C; Liu P; Duan X; Cheng M; Xu LX
    Onco Targets Ther; 2019; 12():4359-4377. PubMed ID: 31213851
    [No Abstract]   [Full Text] [Related]  

  • 51. 17-Beta-estradiol inhibits transforming-growth-factor-beta-induced MCF-7 cell migration by Smad3-repression.
    Malek D; Gust R; Kleuser B
    Eur J Pharmacol; 2006 Mar; 534(1-3):39-47. PubMed ID: 16497293
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Impaired TGF-β signaling and a defect in resolution of inflammation contribute to delayed wound healing in a female rat model of type 2 diabetes.
    Al-Mulla F; Leibovich SJ; Francis IM; Bitar MS
    Mol Biosyst; 2011 Nov; 7(11):3006-20. PubMed ID: 21850315
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Inhibition of transforming growth factor beta signaling in MCF-7 cells results in resistance to tumor necrosis factor alpha: a role for Bcl-2.
    Tobin SW; Brown MK; Douville K; Payne DC; Eastman A; Arrick BA
    Cell Growth Differ; 2001 Feb; 12(2):109-17. PubMed ID: 11243465
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Transforming growth factor-beta1 activates interleukin-6 expression in prostate cancer cells through the synergistic collaboration of the Smad2, p38-NF-kappaB, JNK, and Ras signaling pathways.
    Park JI; Lee MG; Cho K; Park BJ; Chae KS; Byun DS; Ryu BK; Park YK; Chi SG
    Oncogene; 2003 Jul; 22(28):4314-32. PubMed ID: 12853969
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Relationship of fiber surface iron and active oxygen species to expression of procollagen, PDGF-A, and TGF-beta(1) in tracheal explants exposed to amosite asbestos.
    Dai J; Churg A
    Am J Respir Cell Mol Biol; 2001 Apr; 24(4):427-35. PubMed ID: 11306436
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Transforming growth factor-beta1-mediated activation of NF-kappaB contributes to enhanced ADAM-12 expression in mammary carcinoma cells.
    Ray A; Dhar S; Ray BK
    Mol Cancer Res; 2010 Sep; 8(9):1261-70. PubMed ID: 20688878
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Ganoderma lucidum inhibits proliferation of human breast cancer cells by down-regulation of estrogen receptor and NF-kappaB signaling.
    Jiang J; Slivova V; Sliva D
    Int J Oncol; 2006 Sep; 29(3):695-703. PubMed ID: 16865287
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Iron chelation inhibits NF-kappaB-mediated adhesion molecule expression by inhibiting p22(phox) protein expression and NADPH oxidase activity.
    Li L; Frei B
    Arterioscler Thromb Vasc Biol; 2006 Dec; 26(12):2638-43. PubMed ID: 16973969
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Expression of TNF-alpha leader sequence renders MCF-7 tumor cells resistant to the cytotoxicity of soluble TNF-alpha.
    Yan D; Qin N; Zhang H; Liu T; Yu M; Jiang X; Feng W; Wang J; Yin B; Zhang T; Zhou M; Li Z
    Breast Cancer Res Treat; 2009 Jul; 116(1):91-102. PubMed ID: 18618239
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Single live cell TGF-β signalling imaging: breast cancer cell motility and migration is driven by sub-populations of cells with dynamic TGF-β-Smad3 activity.
    Luwor RB; Hakmana D; Iaria J; Nheu TV; Simpson RJ; Zhu HJ
    Mol Cancer; 2015 Feb; 14():50. PubMed ID: 25744371
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.